Hu et al. have found that KCNQ1OT1 up-regulates the expression of ABCC1, thereby increasing the chemotherapy resistance of oxaliplatin to hepatocellular carcinoma (Sun et al. 2018b). The gene discussed is ABCC1; the disease is hepatocellular carcinoma.